Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: April 19, 2018

DrugPatentWatch Database Preview

Chartwell Molecules Company Profile

« Back to Dashboard

What is the competitive landscape for CHARTWELL MOLECULES, and what generic and branded alternatives to CHARTWELL MOLECULES drugs are available?

CHARTWELL MOLECULES has twenty approved drugs.

Summary for Chartwell Molecules

US Patents:	0
Tradenames:	15
Ingredients:	15
NDAs:	20

Drugs and US Patents for Chartwell Molecules

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Chartwell Molecules	ONDANSETRON	ondansetron	TABLET, ORALLY DISINTEGRATING;ORAL	077406-004	Dec 26, 2006		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Chartwell Molecules	SELEGILINE HYDROCHLORIDE	selegiline hydrochloride	TABLET;ORAL	074641-001	Aug 2, 1996		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Chartwell Molecules	SULFAMETHOXAZOLE AND TRIMETHOPRIM	sulfamethoxazole; trimethoprim	TABLET;ORAL	078060-001	Jan 25, 2007	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Chartwell Molecules	DISULFIRAM	disulfiram	TABLET;ORAL	091563-002	Dec 31, 2012	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office

US Army

Baxter

Fuji

Deloitte

Fish and Richardson

Julphar

Harvard Business School

Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.